| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.53 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |